Piotr Czempik: Viscoelastic Testing Guiding Lumbar Puncture in Waldenström’s Macroglobulinemia
Piotr Czempik, Chair of Department of Anesthesiology and Intensive Care at Medical University of Silesia, shared on LinkedIn about a recent article he and his colleague co-authored, adding:
”Viscoelastic testing to guide lumbar puncture in Waldenström’s macroglobulinemia
Patients with Waldenström’s macroglobulinemia often have unpredictable bleeding risks — especially when treated with BTK inhibitors.
In our recent case, a patient with thrombocytopenia (PLT 58 × 10⁹/L) required a lumbar puncture.
Traditional coagulation tests offered limited clarity.
Using ROTEM, we assessed global hemostasis and found preserved platelet contribution to clot strength, despite low PLT count and BTKi therapy.
Based on this, we proceeded without prophylactic platelet transfusion, and the procedure was complication‑free.
Key message:
In complex hematologic conditions, platelet count alone may be misleading. Viscoelastic hemostasis assays can support safer, more individualized procedural decisions.”
Title: Viscoelastic hemostasis assessment before a lumbar puncture in a thrombocytopenic patient with Waldenström’s macroglobulinemia managed with Bruton tyrosine kinase inhibitor — a case report
Authors: Piotr Czempik, Justyna Tabaka-Pradela
Read the Full Article on Acta Haematologica Polonica
Stay updated on all scientific advances with Hemostasis Today.
-
May 24, 2026, 00:54Andreas Ejlegard: The Promise of Smarter Antithrombotic Therapy with Cereno Scientific
-
May 24, 2026, 00:43Patient Advocacy and Clinical Excellence United at the European Certificate in Clinical Haemostasis – EHC
-
May 24, 2026, 00:41Mass General Brigham Research: Advancing the Future of Gene and Cell Therapy
-
May 23, 2026, 16:55Rahul Bhargava: Ensure Equal Recognition of Clinical Haematologists in Blood Cancer Clinical Trials
-
May 23, 2026, 16:44Brian O Mahony: World Haemophilia Day Receives Global WHO Recognition
-
May 23, 2026, 16:44Yusuf Hameed: Gene Therapy Could Reduce Lifetime Treatment Burden in Hemophilia A
-
May 23, 2026, 16:43Chokri Ben Lamine: Pacritinib Is a Key JAK Inhibitor for Cytopenic Myelofibrosis
-
May 23, 2026, 16:42Bartosz Hudzik: Bleeding Risk Alone Should Not Determine Treatment Intensity
-
May 23, 2026, 16:42Shimels Tessema: Celebrating the WHA Resolution on Hemophilia and Other Bleeding Disorders